PodcastsBusinessHow I Invest with David Weisburd

How I Invest with David Weisburd

David Weisburd
How I Invest with David Weisburd
Latest episode

367 episodes

  • How I Invest with David Weisburd

    E364: $90B Limited Partner: Why We're (Still) Bullish on Large VC Funds

    05/07/2026 | 39 mins.
    What if venture capital isn’t an asset class—but an access game where only a few managers matter?

    In this episode, I sit down with Nolan Bean, CIO at FEG Investment Advisors, to discuss how institutional investors are adapting to a world where companies stay private longer and AI is reshaping every asset class. Nolan breaks down why access to top-tier managers matters more than allocation, how venture portfolios are evolving to include both early-stage and multi-stage exposure, and why DPI, liquidity, and portfolio construction are becoming more complex. We also explore portable alpha, diversification myths, and how allocators think about risk in a world where everything is increasingly correlated.
  • How I Invest with David Weisburd

    E363: How Nigel Morris Built QED into a Fintech Powerhouse

    05/06/2026 | 58 mins.
    What if the real edge in venture capital isn’t picking companies—but helping them survive long enough to matter?

    In this episode, I sit down with Nigel Morris, Managing Partner at QED Investors and Co-Founder of Capital One, to discuss how fintech innovation actually happens and why most investors misunderstand the role of venture capital. Nigel explains why incumbents struggle to innovate despite massive advantages, how QED built one of the most successful fintech franchises by combining operating experience with investing, and why venture is not stock picking but hands-on company building. We also explore founder psychology, power laws, and how culture and talent ultimately determine outcomes more than strategy or capital.
  • How I Invest with David Weisburd

    E362: Why Jensen Huang Believes Physical AI will be a $50 Trillion Market

    05/05/2026 | 31 mins.
    What if the biggest opportunity in AI isn’t intelligence—but the missing data layer for the physical world?

    In this episode, I sit down with Daniel Jacker, CEO and Co-Founder of ZaiNar, to discuss why physical AI could become a $50 trillion market and the infrastructure required to make it work. Daniel explains how turning wireless networks into a real-time sensing layer unlocks entirely new capabilities across industries, why the absence of physical-world data is the biggest bottleneck in AI today, and how his company spent nearly a decade in stealth building a foundational technology before scaling. We also explore swarm intelligence, robotics, and where value will accrue as AI moves from digital to physical environments.
  • How I Invest with David Weisburd

    E361: Why Venture Capital is Not an Asset Class

    05/04/2026 | 42 mins.
    What if venture capital isn’t really an asset class—but a game where only a handful of managers actually matter?

    In this episode, I sit down with Ian Sigalow, Co-Founder and Managing Partner of Greycroft, to discuss why venture returns are driven by a small group of firms with consistent access to the best companies. Ian explains why diversification often hurts venture outcomes, how the industry splits between “access” and “craft” investing, and why conviction, not consensus, drives results. We also explore what defines great founders in the AI era, how venture firms build brand and culture over decades, and why the intersection of multiple skill sets is becoming the foundation for generational companies.
  • How I Invest with David Weisburd

    E360: The Hardest Lessons I Learned from Building 4 Unicorns

    05/01/2026 | 54 mins.
    What if the biggest breakthroughs in biotech don’t come from more capital—but from building better systems for innovation?

    In this episode, I sit down with Errik Anderson, biotech entrepreneur and founder behind multiple billion-dollar companies, to discuss how building infrastructure, not just drugs, is reshaping the future of healthcare. Errik explains why most biotech companies fail the same way, how reducing the cost and time of experimentation unlocks more innovation, and why staying private longer enables better long-term decision making. We also explore compounding in biotech, the limits of scaling creativity, and how conviction, mission, and talent ultimately determine which companies change the world.

More Business podcasts

About How I Invest with David Weisburd

How I Invest with David Weisburd is a podcast that interviews the world's leading institutional investors. Previous guests include The Ford Foundation, Northwestern University Endowment, CalPERS, Stepstone, and other top limited partners.
Podcast website

Listen to How I Invest with David Weisburd, The Learning Leader Show With Ryan Hawk and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Social
v8.8.15| © 2007-2026 radio.de GmbH
Generated: 5/8/2026 - 2:26:55 AM